These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10958872)

  • 41. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.
    Williamson MP; Elder PA; Shaw ME; Devlin J; Knowles MA
    Hum Mol Genet; 1995 Sep; 4(9):1569-77. PubMed ID: 8541841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers.
    Okajima E; Fukuda T; Okita S; Tsutsumi M; Hirao Y; Okajima E; Konishi Y
    Cancer Lett; 1996 Jun; 103(2):227-31. PubMed ID: 8635161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A; Robertson JT; Ali IU
    Oncogene; 1996 Aug; 13(3):661-4. PubMed ID: 8760309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients.
    Bassi CL; Martelli L; Cipolotti R; Scrideli CA; Defávery R; Tone LG
    Braz J Med Biol Res; 2004 Nov; 37(11):1683-7. PubMed ID: 15517085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
    Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer.
    Yeh KT; Chang JG; Lin TH; Wang YF; Tien N; Chang JY; Chen JC; Shih MC
    Oncol Rep; 2003; 10(3):659-63. PubMed ID: 12684640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the tumour suppressor genes p15 and p16 in malignant melanoma.
    Robinson WA; Elefanty AG; Hersey P
    Melanoma Res; 1996 Aug; 6(4):285-9. PubMed ID: 8873047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
    Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
    J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer.
    Heidenreich B; Heidenreich A; Sesterhenn A; Srivastava S; Moul JW; Sesterhenn IA
    Eur Urol; 2000 Oct; 38(4):475-82. PubMed ID: 11025389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Codeletion of p15 and p16 in primary malignant mesothelioma.
    Xio S; Li D; Vijg J; Sugarbaker DJ; Corson JM; Fletcher JA
    Oncogene; 1995 Aug; 11(3):511-5. PubMed ID: 7630635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias.
    Nakamaki T; Kawamata N; Schwaller J; Tobler A; Fey M; Pakkala S; Lee YY; Kim BK; Fukuchi K; Tsuruoka N
    Br J Haematol; 1995 Sep; 91(1):139-49. PubMed ID: 7577621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of alterations in the tumor suppressor genes INK4A and INK4B in human bladder tumors.
    Orlow I; Cordon-Cardo C
    Methods Mol Biol; 2002; 179():43-59. PubMed ID: 11692873
    [No Abstract]   [Full Text] [Related]  

  • 55. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions.
    Kumanishi T; Zhang S; Ichikawa T; Endo S; Washiyama K
    Jpn J Cancer Res; 1996 Jul; 87(7):691-5. PubMed ID: 8698617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Deletion of p15 and p16 genes and overexpression of STK15 gene in human laryngeal squamous cell carcinoma].
    Li FC; Li YH; Zhao X; Kang N; Fu WN; Xu ZM; Li ZG; Sun KL
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):316-9. PubMed ID: 12812651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L; Eymin B; Brambilla E; Gazzeri S
    Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation.
    Wong IH; Ng MH; Lee JC; Lo KW; Chung YF; Huang DP
    Br J Haematol; 1998 Oct; 103(1):168-75. PubMed ID: 9792305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.